Recent 13F filings as of December 2025 show that 182 institutional investors hold a position in Editas Medicine, Inc. (NASDAQ:EDIT).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 9,347,114 | 1,327,223 | 16.55% | $19,161,582.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 8,208,068 | 1,242,450 | 17.84% | $16,826,539.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 3,039,778 | 1,762,378 | 137.97% | $6,231,545.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,284,740 | 244,574 | 11.99% | $4,684,759.00 |
| Nuveen, LLC | 31 Dec, 2025 | 1,976,900 | -114,736 | -5.49% | $4,052,645.00 |
| STATE STREET CORP | 31 Dec, 2025 | 1,974,931 | 49,887 | 2.59% | $4,048,609.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,632,584 | 48,429 | 3.06% | $3,346,797.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 1,224,100 | 19,100 | 1.59% | $2,509,405.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 1,211,680 | 659,985 | 119.63% | $2,483,944.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 1,109,590 | 993,411 | 855.07% | $2,274,659.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 881,960 | 423,684 | 92.45% | $1,808,018.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Dec, 2025 | 827,140 | 27,117 | 3.39% | $1,695,637.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 820,993 | 458,800 | 126.67% | $1,683,035.00 |
| UBS Group AG | 31 Dec, 2025 | 809,342 | 386,948 | 91.61% | $1,659,151.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 799,847 | 443,189 | 124.26% | $1,635.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 794,671 | 14,716 | 1.89% | $1,629,076.00 |
| JPMORGAN CHASE & CO | 31 Dec, 2025 | 783,104 | -37,563 | -4.58% | $1,605,363.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 733,483 | 733,483 | 0.00% | $1,503,640.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 704,662 | -94,548 | -11.83% | $1,444,557.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 678,913 | -408,994 | -37.59% | $1,391,772.00 |